Prospective validation and mechanistic studies are warranted.<h4>Significance</h4>Natural autoantibodies (ANA) are routinely measured, inexpensive, and widely accessible, yet their prognostic value in cirrhosis is not used for HCC risk stratification. The gene discussed is BTG3; the disease is Cirrhosis.